West Pharmaceutical Services Inc (WST)vsZEN Graphene Solutions Ltd (ZTEK)
WST
West Pharmaceutical Services Inc
$247.02
+0.71%
HEALTHCARE · Cap: $17.68B
ZTEK
ZEN Graphene Solutions Ltd
$0.57
-2.75%
HEALTHCARE · Cap: $63.02M
Smart Verdict
WallStSmart Research — data-driven comparison
West Pharmaceutical Services Inc generates 325933% more annual revenue ($3.07B vs $942,880). WST leads profitability with a 16.1% profit margin vs 0.0%. WST earns a higher WallStSmart Score of 55/100 (C-).
WST
Buy55
out of 100
Grade: C-
ZTEK
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-256.8%
Fair Value
$68.99
Current Price
$247.02
$178.03 premium
Intrinsic value data unavailable for ZTEK.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.6%
Revenue surging 73.1% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
2.1% earnings growth
Expensive relative to growth rate
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -56.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : WST
The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.
Bull Case : ZTEK
The strongest argument for ZTEK centers on Revenue Growth, Debt/Equity. Revenue growth of 73.1% demonstrates continued momentum.
Bear Case : WST
The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.
Bear Case : ZTEK
The primary concerns for ZTEK are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
WST profiles as a mature stock while ZTEK is a hypergrowth play — different risk/reward profiles.
WST carries more volatility with a beta of 1.18 — expect wider price swings.
ZTEK is growing revenue faster at 73.1% — sustainability is the question.
WST generates stronger free cash flow (175M), providing more financial flexibility.
Bottom Line
WST scores higher overall (55/100 vs 23/100), backed by strong 16.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
ZEN Graphene Solutions Ltd
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ZEN Graphene Solutions Ltd (ZTEK) is a pioneering company in the field of materials technology, dedicated to the development and commercialization of graphene-based solutions that enhance a wide array of industrial applications. With its innovative proprietary extraction techniques, ZTEK produces high-purity graphene from natural graphite, aiming to revolutionize sectors such as environmental remediation, energy storage, and advanced manufacturing. The company’s robust focus on sustainability and continuous investment in research and development underscores its commitment to leading the graphene technology market. As ZTEK navigates opportunities for growth and innovation, it stands well-positioned to drive long-term shareholder value and meet the rising global demand for high-performance materials.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?